Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.279
+0.013 (4.85%)
Dec 20, 2024, 4:00 PM EST - Market closed
Biomerica Employees
Biomerica had 64 employees as of May 31, 2024. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$86,078
Profits / Employee
-$96,281
Market Cap
4.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sintx Technologies | 43 |
Predictive Oncology | 35 |
Healthcare Triangle | 31 |
Sonnet BioTherapeutics Holdings | 12 |
Galmed Pharmaceuticals | 8 |
Lixte Biotechnology Holdings | 4 |
BMRA News
- 4 weeks ago - Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis - GlobeNewsWire
- 6 weeks ago - Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements - GlobeNewsWire
- 7 weeks ago - Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - GlobeNewsWire
- 2 months ago - Biomerica Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 3 months ago - The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - GlobeNewsWire
- 4 months ago - Biomerica Reports Fiscal 2024 Year End Results - GlobeNewsWire
- 6 months ago - Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - GlobeNewsWire
- 7 months ago - Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 - GlobeNewsWire